cancer.about.com/cs/acutemyeloid/
·
Save
Meds.com:
Acute Myelogenous LeukemiaAdult
Acute Myeloid
Leukemia — (physician version) —The National Cancer Institute ...
Acute Myelogenous Leukemia: A Patient Guide from ...Cancer Information Center |
Leukemia | Colon Cancer | Lung Cancer | ...Meds.com offers medical information and education on cancer (lung cancer, colon cancer, breast cancer,
leukemia) and HIV / AIDS for patients, ...MedlinePlus:
Leukemia, Adult
AcuteDetailed information about the disease from the National Institutes of Health. Provides overview of adult
acute leukemia, news, treatment, ...Benzene Exposure Lawsuit - Benzene,
Leukemia,Lawyer,Attorney,Lawsui ...... for instances of
acute myelogenous leukemia,
acute lymphocytic
leukemia, chronic
myelogenous leukemia, in addition to other forms of ...Benzene Lawyer Attorney - AML
Leukemia | Benzene Exposure | Benzene ...... include
acute myelogenous leukemia (AML
leukemia),
acute lymphocytic
leukemia (ALL), chronic
myelogenous leukemia (CML), chronic ...eMedicine:
Acute Myelogenous LeukemiaAcute Myelogenous Leukemia -
Acute myelogenous leukemia (AML) is a malignant disease of the bone marrow in which hematopoietic precursors are ...INNOVIVE Pharmaceuticals Presents Data on Oncology Drug Programs in ...... for Gleevec-resistant or intolerant chronic
myelogenous leukemia, and INNO-305, a peptide immunotherapy for the treatment of
acute ...related
Acute Myelogenous Leukemia Explanation, Aml, Stages of
Acute Myelogenous Leukemia, Chronic
Myelogenous Leukemia, Treatment for
Acute Myelogenous Leukemia, End Stages of
Acute Myelogenous Leukemia, Adult
Acute Myelogenous Leukemia, History of
Acute Myelogenous Leukemia, Causes of
Acute Myelogenous Leukemia, Patients Who Had
Acute Myelogenous Leukemia,
Acute Myelogenous Leukemia Prognosis, Subtypes of
Acute Myelogenous Leukemia,
Acute Myelogenous Leukemia Diagnosis,
Acute Myelogenous Leukemia Consolidation, Is
Acute Myelogenous Leukemia Hereditary?,
Acute Myelogenous Leukemia Survival,
Acute Myelogenous Leukemia Support Groups,
Acute Myelogenous Leukemia Relapse,
Acute Lymphocytic
Leukemia, Adult
Acute Myeloid
Leukemia,
Acute Myeloid
Leukemia Symptoms, Bone Marrow Transplant,
Acute Promyelocytic
Leukemia, Disease
Leukemia,
Acute Myelocytic
Leukemia, Myelodysplastic Syndrome, How Much Does Chemotherapy Cost?, Death from
Leukemia, Cancers, Causes of Swollen Lymph Nodes in Neck, Blood Cancer,
Acute Lymphoblastic
Leukemia, Dec. 11: U of M study finds children with leukemia living longer... - More than 90 percent of children and young adults who survive five years or longer after diagnosis and treatment for acute myeloid
leukemia (AML) (also known as acute myelogenous leukemia or acute nonlymphocytic leukemia) are alive 20 years later ... Drug Combination Studied In Leukemia'sCancer researchers are conducting a clinical trial to study a combination of drugs they hope will provide a less toxic and more effective alternative for patients with acute myelogenous
leukemia and ... Life sciences in brief... abnormal growth of cancer cells. The drug could treat a broad range of cancers, including liver and prostate cancer, acute myelogenous
leukemia and ovarian cancer. Trials begin this month and will run through 2007. -- Star report ... Lilly Highlights Two Collaboration Drugs in Its Pipeline Update... it is initiating Phase 2 trials for survivin ASO in a broad range of cancers including liver cancer,
prostate cancer, acute myelogenous
leukemia, ovarian cancer and non-small cell
lung cancer; the first of these trials is planned to begin this ... Dacogen(TM) (Decitabine) for Injection Data Presented at the American ...MGI PHARMA, INC. , a biopharmaceutical company focused in oncology and acute care, today provided a summary of the Dacogen for Injection presentations made during the American Society of Hematology 48 th Annual ... Cytokinetics Announces Non-Clinical Poster Presentation Regarding...... tumors that have failed to respond to all standard therapies and the other clinical trial is enrolling patients with acute leukemia, chronic myelogenous leukemia or advanced myelodysplastic syndromes. In addition, the NCI plans to initiate a Phase ... Positive Data Reported for MethylGene's MGCD0103, an Oral, Isotype-Selective HDAC Inhibitor... inhibitor MGCD0103 in combination with azacitidine in patients with high-risk Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)" described interim results for 23 patients with MDS or AML at dose levels of MGCD0103 ranging from 35 ... Gemin X Phase 1 Data Show Clinical Activity of GX15-070 in Myelodysplastic Syndromes... agent via 24-hour continuous infusion every two weeks in patients with myeloid malignancies and chronic lymphocytic
leukemia (CLL). The data indicate that prolonged infusion of GX15-070 induced clinical and biological activity with minimal ... Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows...Kosan Biosciences Incorporated presented results from a Phase 1 clinical trial of its second-generation Hsp90 inhibitor, alvespimycin HCl , showing encouraging signs of anti-leukemia activity in a highly ... Lilly cancer drug will start new trials... e abnormal growth of
cancer cells. The drug could treat a broad range of cancers, including liver and prostate cancer, acute myelogenous leukemia and ovarian cancer. The trials will begin this month and last through next year. Positive Data Reported at ASH Annual Meeting for MethylGene's...... inhibitor MGCD0103 in combination with azacitidine in patients with high-risk Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)" described interim results for 23 patients with MDS or AML at dose levels of MGCD0103 ranging from 35 ... Merck and Vertex Announce Phase I Results for Investigational Aurora Disorders... University Medical Center, showed that MK-0457 demonstrated clinical activity in select patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphocytic leukemia (Ph+ ALL) with the T315I BCR- ABL mutation and ... Merck and Vertex Announce Phase I Results for Investigational Aurora...... University Medical Center, showed that MK-0457 demonstrated clinical activity in select patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphocytic leukemia (Ph+ ALL) with the T315I BCR-ABL mutation and ... Lilly, Isis ready for second-phase cancer trials... second phase for survivin ASD, a drug that could treat a broad range of cancers, including liver and prostate cancer, acute myelogenous leukemia and ovarian cancer. The trials would begin this month and last through next year. Genta Provides Update On Analysis Of Phase 3 Trial Of Genasense(R) In ...... or without Genasense(R) (oblimersen sodium) Injection that was conducted in older, previously untreated patients with acute myelogenous
leukemia. According to the analysis conducted by the Cancer and Leukemia Group B, the
trial failed to meet its ... Mary McCarty: 13-year-old's battle with leukemia leaves lasting impression on familyLast Christmas, 13-year-old Leo Johnson knew his leukemia had relapsed. He understood what that meant. Little Boy Needs Marrow DonorBy : Tim Szostek : 12/8/06 Two-year-old Harrison Leonardo, who lives in
San Leandro, is fighting
leukemia and is in desperate need of a bone marrow transplant. Friday's biggest stock gainers and decliners... a Phase III trial of chemotherapy with or without Genasense, conducted in older, previously untreated patients with acute myelogenous leukemia, failed to meet its primary endpoint of overall survival. Shares of Questcor Pharmaceuticals ( QSC : QSC , ... Childhood, Youth Cancer Survival Factors Vary by Race, Follow-Up CareCancer is the leading cause of disease-related death among children in the U.S. The numbers of newly diagnosed patients across the major childhood cancers, such as leukemia and
lymphoma, continue to escalate. New Chemotherapy Combinations and Alternatives for Blood Cancers...... can produce the same results without causing additional harm. This is particularly important in blood cancers like leukemia and lymphoma, and three studies being presented today at the 48th Annual Meeting of the American Society of Hematology ...
4 CommentsPositive Data Reported at ASH Annual Meeting for MethylGene's...... inhibitor MGCD0103 in combination with azacitidine in patients with high-risk Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)" described interim results for 23 patients with MDS or AML at dose levels of MGCD0103 ranging from 35 ... Merck and Vertex Announce Phase I Results for Investigational Aurora Disorders... University Medical Center, showed that MK-0457 demonstrated clinical activity in select patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphocytic leukemia (Ph+ ALL) with the T315I BCR- ABL mutation and ... Merck and Vertex Announce Phase I Results for Investigational Aurora...... University Medical Center, showed that MK-0457 demonstrated clinical activity in select patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphocytic leukemia (Ph+ ALL) with the T315I BCR-ABL mutation and ... Lilly, Isis ready for second-phase cancer trials... second phase for survivin ASD, a drug that could treat a broad range of cancers, including liver and prostate cancer, acute myelogenous leukemia and ovarian cancer. The trials would begin this month and last through next year. Genta Provides Update On Analysis Of Phase 3 Trial Of Genasense(R) In ...... or without Genasense(R) (oblimersen sodium) Injection that was conducted in older, previously untreated patients with acute myelogenous leukemia. According to the analysis conducted by the Cancer and Leukemia Group B, the trial failed to meet its ... Mary McCarty: 13-year-old's battle with leukemia leaves lasting impression on familyLast Christmas, 13-year-old Leo Johnson knew his leukemia had relapsed. He understood what that meant. Little Boy Needs Marrow DonorBy : Tim Szostek : 12/8/06 Two-year-old Harrison Leonardo, who lives in San Leandro, is fighting leukemia and is in desperate need of a bone marrow transplant. Friday's biggest stock gainers and decliners... a Phase III trial of chemotherapy with or without Genasense, conducted in older, previously untreated patients with acute myelogenous leukemia, failed to meet its primary endpoint of overall survival. Shares of Questcor Pharmaceuticals ( QSC : QSC , ... Childhood, Youth Cancer Survival Factors Vary by Race, Follow-Up CareCancer is the leading cause of disease-related death among children in the U.S. The numbers of newly diagnosed patients across the major childhood cancers, such as leukemia and lymphoma, continue to escalate. New Chemotherapy Combinations and Alternatives for Blood Cancers...... can produce the same results without causing additional harm. This is particularly important in blood cancers like leukemia and lymphoma, and three studies being presented today at the 48th Annual Meeting of the American Society of Hematology ...